( January 3, 2025, 1:20 PM EST) -- FORT WORTH, Texas — Objections to a motion to intervene filed by Eli Lilly and Co. in a suit brought by companies representing the interests of drug compounders that challenge the U.S. Food and Drug Administration’s decision to remove two FDA-approved drugs for diabetes and weight loss from the agency’s drug shortage list must be filed by Jan. 15, a Texas federal judge ordered Jan. 2....